This document discusses central line-associated bloodstream infections (CLABSIs). It begins with an introduction that defines CLABSIs and explains their impact and preventability. It then covers the definition of CLABSIs, pathogenesis and risk factors. Proven prevention strategies are discussed such as hand hygiene, maximal sterile barriers, antisepsis, site selection, chlorhexidine dressings and daily bathing. The impacts of non-clinical factors like regulations and tracking methods are reviewed. Finally, the document discusses the effects of the COVID-19 pandemic on CLABSI rates and prevention practices. The conclusion calls for more robust and flexible prevention systems.
Prevention of Central Line–Associated Bloodstream Infections (CLABSI) prevention.pptx
1.
2. 8-Conclusion
7-COVID-19 Pandemic and CLABSI
6-Non-Clinical Factors and CLABSI
5-Proven Preventive Strategies and
Devices
4-Risk Factors for CRBSI
3-Pathogenesis
2-Definition of CLABSI
1-Introduction
3. 8-Conclusion
7-COVID-19 Pandemic and CLABSI
6-Non-Clinical Factors and CLABSI
5-Proven Preventive Strategies and
Devices
4-Risk Factors for CRBSI
3-Pathogenesis
1-Introduction
2-Definition of CLABSI
4. 8-Conclusion
7-COVID-19 Pandemic and CLABSI
6-Non-Clinical Factors and CLABSI
5-Proven Preventive Strategies and
Devices
4-Risk Factors for CRBSI
1-Introduction
2-Definition of CLABSI
3-Pathogenesis
5. 8-Conclusion
7-COVID-19 Pandemic and CLABSI
6-Non-Clinical Factors and CLABSI
5-Proven Preventive Strategies and
Devices
1-Introduction
2-Definition of CLABSI
3-Pathogenesis
4-Risk Factors for CRBSI
6. 8-Conclusion
7-COVID-19 Pandemic and CLABSI
6-Non-Clinical Factors and CLABSI
1-Introduction
2-Definition of CLABSI
3-Pathogenesis
4-Risk Factors for CRBSI
5-Proven Preventive Strategies and
Devices
7. 8-Conclusion
7-COVID-19 Pandemic and CLABSI
1-Introduction
2-Definition of CLABSI
3-Pathogenesis
4-Risk Factors for CRBSI
5-Proven Preventive Strategies and
Devices
6-Non-Clinical Factors and CLABSI
10. 1-Introduction
In ICU, many medical and surgical conditions often involves long-
term infusion of:
• Intravenous fluids.
• Broad-spectrum antibiotics.
• Chemotherapeutic agents for cancer.
• Critical care therapies.
• Total parenteral nutrition, or hemodialysis.
For these interventions, central venous catheters.
“provide safe and reliable vascular access”.
11. 1-Introduction
Central venous catheters carries the risk for infection with
subsequent Increase in:
• Antibiotic exposure.
• Hospital stay.
• Health care costs.
• The risk of death.
12. 1-Introduction
Studies showed that CLABSIs are Often preventable.
• CLABSI is associated with
enormous morbidity and
mortality burden.
• Often preventable.
13. 1-Introduction
For this, efforts have been made by several governmental,
public health, and professional organizations to sponsor and
promote evidence-based guidelines for strategies to prevent
CLABSI.
14. 1-Introduction
These efforts have been recognized for successfully reducing
the occurrence of CLABSI in healthcare systems.
58%
2001 2009
AFTER APPLICATION OF PREVENTIVE STRATEGIES
After application of preventive strategies
2.5/1000
0.76/1000
2004 2013
AFTER APPLICATION OF PREVENTIVE STRATEGIES
After Application of preventive strategies
16. CLABSI vs CRBSI
2-Definition of CLABSI
CRBSI
CLABSI:
a laboratory-confirmed bloodstream
infection in a patient who has had a
central venous catheter in place for
more than 48 hours before the date on
which blood was drawn for culture, if
no other source of bacteremia or
fungemia is identified.
17. CLABSI vs CRBSI
2-Definition of CLABSI
CLABSI:
a laboratory-confirmed bloodstream
infection in a patient who has had a
central venous catheter in place for
more than 48 hours before the date on
which blood was drawn for culture, if
no other source of bacteremia or
fungemia is identified.
CRBSI:
CLABSI + clinical and
laboratory criteria
18. Is it adequate for diagnosis to solely take a culture from the
catheter tip instead of obtaining a blood culture?
19. Catheter tip cultures are no longer recommended for CRBSI
diagnosis, given low positive predictive value.
catheter tip cultures should not be used in place of blood
specimens
The blood culture bottles should be labeled to reflect the sites
from which the cultures were obtained. Ideally, at least two sets
of blood cultures should be obtained from peripheral veins via
separate venipuncture sites prior to initiation of antibiotic
therapy.
Is it adequate for diagnosis to solely take a culture from the
catheter tip instead of obtaining a blood culture?
20. 3-Pathogenesis
Routes for catheter contamination:
“By Hospital Staff”
1. skin pathogens at the insertion site.
Most commonly happens within the
first 7 days after catheter placement.
21. 3-Pathogenesis
Routes for catheter contamination:
the number of times the catheter is manipulated or accessed.
“By Hospital Staff”
2. Intraluminal contamination when
the catheter hub is manipulated.
• typically happens more than 7
days after catheter insertion.
• Related to:
the care and maintenance of the
catheter.
2. Intraluminal contamination when
the catheter hub is manipulated.
• typically happens more than 7
days after catheter insertion.
• Related to:
34. 4-Risk Factors for CRBSI
Risk factors are categorized to:
Patient factors.
Provider factors.
Device factors.
35. 4-Risk Factors for CRBSI
Risk factors are categorized to:
Patient factors:
• Immunocompromise
• Neutropenia
• Burns
• Malnutrition
• BMI >40
• Prolonged hospitalization before catheter insertion
• Prematurity in infants
• Limited venous access.
36. 4-Risk Factors for CRBSI
Risk factors are categorized to:
Provider factors:
• Emergency catheter insertion
• Incomplete adherence to aseptic technique
• Multiple manipulations of the catheter
• Low nurse-to-patient ratio
• Failure to remove unnecessary catheter
37. 4-Risk Factors for CRBSI
Risk factors are categorized to:
Device factors:
• Catheter material
• Catheter insertion site
• Indications for use (e.g., for hemodialysis)
38. 5-Proven Preventive Strategies and
Devices
Consist of specific step-by-step instructions on how to insert a
catheter with the use of standard infection-prevention practices
and aseptic technique.
Check-list:
39. Check-list:
Improve adherence to infection-control practices.
Reduce the incidence of infection.
5-Proven Preventive Strategies and
Devices
40. Catheter-insertion Kit or Carts:
Ensuring that everything needing for successful catheter
insertion is in one place.
5-Proven Preventive Strategies and
Devices
41. 5-Proven Preventive Strategies and
Devices
Essential part of an infection-prevention program
Involve washing with:
• Conventional soap and water.
• Or with an alcohol-based, waterless hand rub.
Hand Hygiene:
42. 5-Proven Preventive Strategies and
Devices
CLEAN THEN DRY.
Hand hygiene is essential before and after inserting, replacing,
accessing, repairing, or dressing an intravascular catheter.
Hand Hygiene:
44. 5-Proven Preventive Strategies and
Devices
Defined as wearing a mask, cap, sterile gown, and sterile gloves
and placing a large sterile drape that fully covers the patient’s
entire body.
Maximal Sterile Barrier Precautions:
45. Maximal Sterile Barrier Precautions:
5-Proven Preventive Strategies and
Devices
Is it necessary to employ maximal sterile barrier precautions
during the Central line insertion procedure, or is it sufficient to
wear sterile gloves and utilize a small drape?
46. The use of maximal sterile barrier precautions during catheter
placement has been associated with a reduced incidence of
CLABSI, as compared with the use of sterile gloves and a small
drape alone.
Maximal Sterile Barrier Precautions:
5-Proven Preventive Strategies and
Devices
47. Antisepsis:
5-Proven Preventive Strategies and
Devices
Which of the following antiseptics is considered the most effective option?
A) Povidone Iodine (Betadine).
B) Alcoholic Chlorhexidine.
C) Medical Alcohol 75%.
48. Antisepsis:
5-Proven Preventive Strategies and
Devices
Alcoholic chlorhexidine preparation containing at least 2%
chlorhexidine gluconate at the time of catheter insertion has
become the standard of care.
49. Antisepsis:
5-Proven Preventive Strategies and
Devices
Chlorhexidine has:
More rapid action Persistent activity despite exposure to blood and
body fluids
Shorter drying Longer residual effect at the site of catheter
insertion.
50. Site Selection:
5-Proven Preventive Strategies and
Devices
Which of the following is the preferred catheter insertion site for reducing the risk of
Catheter-Related Bloodstream Infections (CRBSIs) in the ICU ?
A- Subclavian site.
B- Femoral site.
C- Deep Jugular site.
51. Site Selection:
5-Proven Preventive Strategies and
Devices
The subclavian site is the preferred catheter-insertion site for
reducing the risk of CRBSI in the ICU.
52. Site Selection:
5-Proven Preventive Strategies and
Devices
Subclavian Site carries the risk for:
• Pneumothorax.
• Subclavian-artery cannulization.
• Risk of subclavian stenosis in patients for whom catheter is used for
hemodialysis.
54. Chlorhexidine dressings:
5-Proven Preventive Strategies and
Devices
Available in 2 forms:
1. Gel-based chlorhexidine coating on a transparent
dressing.
2. Chlorhexidine-impregnated sponge dressing.
55. Daily Chlorhexidine Bathing:
1. One study, which involved patients on general medical and
surgical wards + Mupirocin>Significant ↓ in CLABSI
2. Studied in patients with cancer > ↓ in CLABSI.
5-Proven Preventive Strategies and
Devices
56. Antibiotic- and Antiseptic-impregnated catheters:
• Very effective in reducing the risk of CLABSI.
• No additional benefit for patient care units with
a very low incidence of CLABSI.
5-Proven Preventive Strategies and
Devices
57. 5-Proven Preventive Strategies and
Devices
“Scrub the hub” campaigns
Antiseptic-containing Hubs and Caps:
Contamination of catheter hubs and caps is a source of CLABSI.
58. 5-Proven Preventive Strategies and
Devices
“Scrub the hub” campaigns
Antiseptic-containing Hubs and Caps:
Contamination of catheter hubs and caps is a source of CLABSI.
59. 5-Proven Preventive Strategies and
Devices
“Scrub the hub” campaigns
Antiseptic-containing Hubs and Caps:
Contamination of catheter hubs and caps is a source of CLABSI.
60. 5-Proven Preventive Strategies and
Devices
“Scrub the hub” campaigns
Antiseptic-containing Hubs and Caps:
Contamination of catheter hubs and caps is a source of CLABSI.
61. 5-Proven Preventive Strategies and
Devices
“Scrub the hub” campaigns
Antiseptic-containing Hubs and Caps:
Contamination of catheter hubs and caps is a source of CLABSI.
62. Antiseptic-containing Hubs and Caps:
5-Proven Preventive Strategies and
Devices
“Scrub the hub” campaigns
Contamination of catheter hubs and caps is a source of CLABSI.
63. Antiseptic-containing Hubs and Caps:
The use of these devices is supported by high-quality evidence
to reduce the risk of CLABSI.
5-Proven Preventive Strategies and
Devices
But They have not been recommended for routine use because they
are not viewed as superior to manual disinfection.
64. Studies showed that CLABSIs are Often preventable.
• CLABSI is associated with
enormous morbidity and
mortality burden.
• Often preventable.
6-Non-Clinical Factors and CLABSI
67. 6-Non-Clinical Factors and CLABSI
CMS
2. Tracking methods:
CLABSI rates depend not only on the definition used but also on
the methods of tracking. “Public reporting is Obligate”
68. 6-Non-Clinical Factors and CLABSI
2. Tracking methods:
CLABSI rates depend not only on the definition used but also on
the methods of tracking. “Public reporting is Obligate”
Current tracking strategies may underestimate the incidence of
CLABSI if bacteremia is attributed to alternative sources of
infection.
The current tracking strategies demonstrate a low level of
reliability.
69. Effects of Covid-19 pandemic on the U.S. health care system:
• Straining hospital resources.
• Exhausting hospital staff.
• Abrupt decrease in hospital admissions for patients with
common conditions (↑in the severity of illness among hospitalized patients)
• Alteration in the patient and provider risk factors for the
development of CLABSI.
7-COVID-19 Pandemic and CLABSI
70. A qualitative feedback from infection-prevention teams
regarding changes in practices after the beginning of the Covid-
19 pandemic:
• Less chlorhexidine bathing.
• Fewer bedside checks on catheters and.
• Disturbance of catheter dressings because of prone
positioning of patients.
• Increased number of traveling nurses and physicians in
response to increased patient volumes. (Not well trained)
7-COVID-19 Pandemic and CLABSI
71. 7-COVID-19 Pandemic and CLABSI
325%
Before After
AFTER COVID-19 PANDEMIC
After COVID-19 Pandemic
72. • The Covid-19 pandemic revealed other vulnerabilities in the
CLABSI-prevention system.
• Collection of data is stopped from January through June
2020.
• This problem highlights the need for a new and simpler
definition that allows for computerized capture of CLABSI
rates with the use of AI.
7-COVID-19 Pandemic and CLABSI
73. • The remarkable success in reducing the incidence of CLABSI.
• Part of the reduction may have been artifactual.
• Despite this success, we should be circumspect, all of this success was
vanished during the first 3 months of the Covid-19 pandemic.
• Fragile CLABSI prevention system and vulnerable to stress.(provider)
• We need to engineer Flexible infection-prevention processes that can
withstand changing environmental conditions
• It is time to consider combining routine use of all available CLABSI
preventive strategies that do not depend on providers.
8-Conclusion